FDA´Â Dynavax Technologies ÀÇ 2ȸ Á¢Á¾ BÇü °£¿° ¹é½Å Heplisav-B¸¦ ½ÂÀÎÇß´Ù.
10ÀÏ(ÇöÁö½Ã°¢) ·ÎÀÌÅÍ Åë½ÅÀº FDA À¥»çÀÌÆ®¸¦ Àοë, ÀÌ°°ÀÌ º¸µµÇß´Ù.
Heplisav-B´Â FDA°¡ 2013³â 2¿ù°ú 2016³â 11¿ù ÀÌ·¸°Ô 2¹ø ½ÂÀÎ °ÅºÎ ÀÌÈÄ ³ª¿Â Dynavax»çÀÇ ÃÖÃÊ ¾à¹°ÀÌ´Ù.
Heplisav-B´Â 3¹ø Á¢Á¾ÇؾßÇÏ´Â GSKÀÇ BÇü °£¿° ¹é½ÅÀÎ '¿£Á¦¸¯½ºB(Engerix B)¿Í °æÀïÇÏ°Ô µÈ´Ù.
¹Ì±¹ ÅõÀÚÀºÇàÀÎ Àª¸®¾ö ºí·¹¾î (William Blair & Company)ÀÇ Katherine Xu ºÐ¼®°¡´Â "µÎ¹ø Á¢Á¾ÇÏ´Â Heplisav-B´Â BÇü °£¿° ¹é½Å ½ÃÀåÀ» ¹Ù²Ü °Í."À̶ó°í ±â´ëÇß´Ù.